European Healthtech startup funding raised during February 2023.
In February 2023, 54 European Healthtech companies raised a combined €580M across 54 funding rounds, down 26.5% versus February 2022. Germany led by capital raised, and European Innovation Council (EIC) was the most active investor. Data as of 9 Jul 2026.
3 exits · €30M disclosed.
| Diamond Whites | Acquisition | Feb 2023 | €30M |
| €28M |
| Evonetix | Series B | Feb 2023 | €22M |
| Tilt Biotherapeutics | Other | Feb 2023 | €22M |
| Icosagen | Debt | Feb 2023 | €18M |
| Syntach | Other | Feb 2023 | €18M |
| Maxion Therapeutics | Series A | Feb 2023 | €15M |
| Oculis | Other | Feb 2023 | €14M |
| DrDoctor | Other | Feb 2023 | €11M |
| Phlo | Series A | Feb 2023 | €11M |
| Dxcover | Series A | Feb 2023 | €11M |
| Resalis Therapeutics | Seed | Feb 2023 | €10M |
| Avicenna.ai | Series A | Feb 2023 | €10M |